SciELO - Scientific Electronic Library Online

 
vol.80 suppl.1Tromboembolismo pulmonar en un adolescente con neumonía COVID-19Heterogeneidad clínica y molecular en los trastornos asociados con CDKL5 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Boletín médico del Hospital Infantil de México

versión impresa ISSN 1665-1146

Resumen

GOITIA-CARDENAS, Mariana; AZOTLA-VILCHIS, Coztli O.  y  MIRANDA-LORA, América L.. Robinow syndrome and its response to growth hormone treatment. Bol. Med. Hosp. Infant. Mex. [online]. 2023, vol.80, suppl.1, pp.40-46.  Epub 11-Sep-2023. ISSN 1665-1146.  https://doi.org/10.24875/bmhim.22000101.

Background:

Robinow syndrome is a rare disease with short stature, characteristic phenotypical abnormalities, and intellectual integrity in most cases.

Case report:

We present the case of a 13-year and one-month-old male who came for medical consultation at 3 years of age due to short stature. Additionally, the patient showed craniofacial dysmorphia, congenital heart disease, and growth hormone deficiency. As per family history, the mother presented the same phenotype. The genetic study identified an unreported variant of the WNT5A gene.

Conclusions:

The patient initiated growth hormone treatment at a dose of 0.7 U/kg/week at 4 years of age with favorable results, increasing his height from the < 1st percentile to the 44th percentile.

Palabras llave : Robinow syndrome; Growth hormone; WNT5A gene.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )